Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Martins

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Recent Patents on Anti-Infective Drug Discovery|April 27, 2011
Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TBMarta Martins
Expert Review of Anti-Infective Therapy|December 18, 2012
Is adjuvant therapy a potential road for fighting Mycobacterium tuberculosis resistance?Marta Martins
Acta Paediatrica (Oslo, Norway : 1992)|March 22, 2016
Healthcare professionals approach paediatric fever in significantly different ways and fever phobia is not just limited to parentsMarta Martins, Francisco Abecasis
Mutagenesis|December 21, 2014
The comet assay in Environmental Risk Assessment of marine pollutants: applications, assets and handicaps of surveying genotoxicity in non-model organismsMarta Martins, Pedro M Costa
Frontiers in Microbiology|October 25, 2016
Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance"Marta Martins, Matthew P McCusker
Future Microbiology|March 28, 2008
The TB laboratory of the future: macrophage-based selection of XDR-TB therapeuticsMarta Martins, Miguel Viveiros, Leonard Amaral
The Journal of Antimicrobial Chemotherapy|January 16, 2007
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumpsLeonard Amaral, Marta Martins, Miguel Viveiros
Microbial Drug Resistance (Larchmont, N.Y.)|July 14, 2018
Reversing Antimicrobial Resistance in Multidrug-Resistant Klebsiella pneumoniae of Clinical Origin Using 1-(1-Naphthylmethyl)-PiperazineJoão Anes, Marta Martins, Séamus Fanning
In Vivo (Athens, Greece)|April 10, 2008
Inhibitors of Ca2+ and K+ transport enhance intracellular killing of M. tuberculosis by non-killing macrophagesMarta Martins, Miguel Viveiros, Leonard Amaral
Porto Biomedical Journal|October 2, 2025
Benzodiazepine use in hospitalized older adults: a retrospective observational studySandra Torres, Marta Martins, Gonçalo Sarmento
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Recent Patents on Anti-Infective Drug Discovery|April 27, 2011
Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TBMarta Martins
Expert Review of Anti-Infective Therapy|December 18, 2012
Is adjuvant therapy a potential road for fighting Mycobacterium tuberculosis resistance?Marta Martins
Acta Paediatrica (Oslo, Norway : 1992)|March 22, 2016
Healthcare professionals approach paediatric fever in significantly different ways and fever phobia is not just limited to parentsMarta Martins, Francisco Abecasis
Mutagenesis|December 21, 2014
The comet assay in Environmental Risk Assessment of marine pollutants: applications, assets and handicaps of surveying genotoxicity in non-model organismsMarta Martins, Pedro M Costa
Frontiers in Microbiology|October 25, 2016
Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance"Marta Martins, Matthew P McCusker
Future Microbiology|March 28, 2008
The TB laboratory of the future: macrophage-based selection of XDR-TB therapeuticsMarta Martins, Miguel Viveiros, Leonard Amaral
The Journal of Antimicrobial Chemotherapy|January 16, 2007
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumpsLeonard Amaral, Marta Martins, Miguel Viveiros
Microbial Drug Resistance (Larchmont, N.Y.)|July 14, 2018
Reversing Antimicrobial Resistance in Multidrug-Resistant Klebsiella pneumoniae of Clinical Origin Using 1-(1-Naphthylmethyl)-PiperazineJoão Anes, Marta Martins, Séamus Fanning
In Vivo (Athens, Greece)|April 10, 2008
Inhibitors of Ca2+ and K+ transport enhance intracellular killing of M. tuberculosis by non-killing macrophagesMarta Martins, Miguel Viveiros, Leonard Amaral
Porto Biomedical Journal|October 2, 2025
Benzodiazepine use in hospitalized older adults: a retrospective observational studySandra Torres, Marta Martins, Gonçalo Sarmento
Pageof 19